12 | Alpha Modus (NASDAQ: AMOD) CEO Doubles Down with | Lee Adams | 06/23/2025 9:26:57 AM |
11 | Alpha Modus Holdings Enters into Funding | Lee Adams | 05/01/2025 9:23:02 AM |
10 | $AMOD News: Alpha Modus Secures Landmark | Lee Adams | 03/17/2025 10:09:44 AM |
9 | $AMOD featured here: From Innovating To | Lee Adams | 03/04/2025 11:56:22 AM |
8 | Alpha Modus Holdings Inc. (NASDAQ: AMOD) Rings | Lee Adams | 02/18/2025 11:19:34 AM |
7 | Alpha Modus (Nasdaq: AMOD) Announces AI-Powered | Lee Adams | 02/13/2025 9:13:33 AM |
6 | $AMOD News: Alpha Modus Announces Strategic ![]() |
Lee Adams | 02/10/2025 9:34:16 AM |
5 | $AMOD News: Alpha Modus Sues Walgreens for Patent | Lee Adams | 02/04/2025 9:41:38 AM |
4 | Alpha Modus Appoints Accomplished Executive | Lee Adams | 01/22/2025 3:35:12 PM |
3 | Alpha Modus Secures 9th AI Patent, Strengthening | Lee Adams | 01/22/2025 3:33:44 PM |
2 | Alpha Modus Files Patent Infringement Lawsuit | Lee Adams | 01/22/2025 3:32:14 PM |
1 | Alpha Modus and Insight Acquisition Corp Close | Lee Adams | 01/22/2025 3:30:45 PM |
Recent Articles
- 4chan and Kiwi Farms Challenge UK Online Safety Legislation
- Taiwanese Brothers Transform Fraser Residence in Jakarta
- Innovative Solar and Storage Technologies Unveiled by Sungrow
- RomReal's Insights and Outcomes from Q2 2025 Unveiled
- Salesforce CEO Marvels at Palantir's Pricing Strategy Impact
- Innovative Leadership Redefines Fraser Residence Sudirman
- Investors Rally for Justice: Join the Lineage, Inc. Lawsuit
- Blumenthal Nordrehaug Bhowmik De Blouw LLP Files Class Action Suit
- Cognizant's Innovative AI Solutions Transforming Enterprise Operations
- Fuzhou's Remarkable Economic Growth and Digital Transformation
- Cybersecurity Breaches Impact Millions: What You Need to Know
- Neogen Corporation Investors Can Seek Justice in Class Action
- Cynthia Lummis Celebrates US GDP Data Shift to Blockchain
- Foresee Pharmaceuticals Celebrates FDA Approval of CAMCEVI ETM
- Innovating Travel: hoppaGo and SAS Enhance Connectivity
- American Rebel Responds to Misleading Media About S-1 Filing
- CamScanner Enhances Document Scanning with New Capture Feature
- Movano Inc. Stock Surges Significantly on Listing Extension News
- Strathcona Resources' Strategic Move to Enhance Shareholding
- Friends of Science Society Raises Concerns Over Net Zero Demands
- Secure Your Rights: Advocating for Replimune Group Investors
- RxSight Securities Class Action: What Investors Need to Know
- Pollo AI Unveils Game-Changing AI Tool for Creators
- Global Leaders Gather for China's Significant 80th V-Day Event
- Gmail's Spam Filtering Under Fire: Is Political Bias at Play?
- Secure Your Rights: Luminar Technologies Investors Alert
- Investors of Sable Offshore Corp. Urged to Act Promptly
- Investors of Lockheed Martin Corporation Must Act Quickly for Class Action
- PharmaResearch Partners with VIVACY to Boost 'Rejuran' in Europe
- Bitcoin Holds Steady While Altcoins Face Disappointing Trends
- PharmaResearch Forms New Alliance for Rejuran Across Europe
- PharmaResearch Partners with VIVACY for Expanded European Reach
- Solar Alliance Energy Inc. Prepares For Market Re-entry After Trading Pause
- SF Intra-city Reports Surge in Revenue and Growth for 2025
- TMC Financing Welcomes Omar Salah as New President and CEO
- Concerns Rise Over Salmonella Outbreak from Eggs in the U.S.
- Top Five Stocks Captivating Investors This Trading Day
- SF Intra-city's Exceptional Performance Fuels Dynamic Growth
- Apex Institute Disrupts Job Training with AI-Driven Bootcamp
- TransUnion Faces Major Data Breach Investigation Amidst Chaos
- Experience Edo Culture Through Unique Tokyo Tours and Cruises
- Soma Gold Corp Posts Strong Financial Results for Q2 2025
- E&R Engineering to Showcase Cutting-Edge Tech at SEMICON 2025
- Exciting Launch of the Mini Labubu Pendant on AliExpress
- Exciting Developments at Freedom Plaza with Local Support
- Netflix Stock Surges as Power Inflow Signals Uptrend
- Exploring E&R's Cutting-Edge Technologies at SEMICON Taiwan
- Mesoblast's Milestones: FDA Approval and Strategic Growth
- Highlights of Mesoblast's Record Year: FDA Approval and Growth
- Replimune Group Inc. Class Action Update for Shareholders